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producer lines as a valuable tool for Plasmodium
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The malaria parasite Plasmodium falciparum replicates inside erythrocytes in the blood of
infected humans. During each replication cycle, a small proportion of parasites commits to
sexual development and differentiates into gametocytes, which are essential for parasite
transmission via the mosquito vector. Detailed molecular investigation of gametocyte biology
and transmission has been hampered by difficulties in generating large numbers of these
highly specialised cells. Here, we engineer P. falciparum NF54 inducible gametocyte producer
(iGP) lines for the routine mass production of synchronous gametocytes via conditional
overexpression of the sexual commitment factor GDV1. NF54/iGP lines consistently achieve
sexual commitment rates of 75% and produce viable gametocytes that are transmissible by
mosquitoes. We also demonstrate that further genetic engineering of NF54/iGP parasites is a
valuable tool for the targeted exploration of gametocyte biology. In summary, we believe the
iGP approach developed here will greatly expedite basic and applied malaria transmission
stage research.
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Malaria is a vector-borne infectious disease caused byprotozoan parasites of the genus Plasmodium. Infec-tions with P. falciparum are responsible for the vast
majority of all malaria-related morbidity and mortality in
humans. Over the last two decades, concerted intervention efforts
targeting both the insect vector and the parasite led to a
remarkable decline in malaria cases worldwide1. However, pro-
gress has come to a standstill in the past few years and in 2019,
malaria was still accountable for 229 million clinical cases and
409,000 deaths, primarily in sub-Saharan Africa2. To further
reduce the spread of malaria, intervention strategies will not only
have to overcome the widespread resistance of mosquitoes and
parasites to insecticides and first-line antimalarial drugs, respec-
tively, but will also have to include efficient tools that interrupt
parasite transmission from the human host to the mosquito
vector3,4.
People get infected with P. falciparum when infested female
Anopheles spp. mosquitoes inject sporozoites into their skin. After
reaching the liver via the bloodstream, sporozoites multiply
within hepatocytes to release thousands of merozoites into cir-
culation. Merozoites invade red blood cells (RBCs) and develop
through the ring and trophozoite stage into a multinucleated
schizont. After daughter cell formation, up to 32 merozoites
egress from the infected RBC (iRBC) to invade and replicate
inside new RBCs. Consecutive rounds of these intraerythrocytic
developmental cycles (IDCs) are responsible for all disease
symptoms and chronic infection. Importantly, however, during
each replication cycle, a small proportion of schizonts produce
sexually committed ring stage progeny that differentiate into
either female or male gametocytes5. When taken up by a mos-
quito, terminally differentiated gametocytes egress from the iRBC
and develop into gametes. The female gametocyte produces one
macrogamete, while the male gametocyte undergoes three rapid
rounds of genome replication followed by exflagellation of eight
motile microgametes. After fertilisation, the zygote transforms
into an ookinete that traverses the midgut epithelium to initiate
sporogony, which ultimately renders the mosquito infectious to
other humans. Hence, as the only forms of the parasite able to
infect mosquitoes, gametocytes are an essential target for future
antimalarial drugs aiming to prevent malaria transmision4.
Gametocytogenesis entails two major processes: sexual commit-
ment/conversion and sexual differentiation. Sexual commitment
occurs during the IDC preceding gametocyte differentiation. This
understanding was gained from experiments showing that all
ring stage descendants derived from a single schizont have the same
fate; they either all undergo another round of intracellular replication
or they all differentiate into either female or male gametocytes6,7. In
addition to this “next cycle sexual conversion (NCC)” process, recent
studies reported “same cycle sexual conversion (SCC)” where ring
stages directly commit to sexual development8,9. Irrespective of the
NCC or SCC routes, sexual conversion is triggered by an epigenetic
switch that activates expression of the master transcription factor
AP2-G10–13. In asexual parasites, heterochromatin-dependent silen-
cing of ap2-g prevents AP2-G expression10,12–14. In a small subset of
trophozoites (NCC) or ring stages (SCC), however, the ap2-g locus
gets activated by molecular mechanisms that are still largely
unknown9–13,15–17. Gametocyte development 1 (GDV1), a nuclear
protein essential for gametocytogenesis in P. falciparum18, plays a key
role in the NCC process16. GDV1 is specifically expressed in sexually
committed trophozoites and schizonts, where it displaces hetero-
chromatin protein 1 (HP1) from the pfap2-g locus, thereby licensing
PfAP2-G expression16. Consistent with the epigenetic control
mechanisms regulating pfap2-g expression, sexual commitment rates
vary in response to environmental changes5. In particular, depletion
of the host serum lipid lysophosphatidylcholine (LysoPC) triggers
sexual commitment in trophozoites and this response is channelled
via induction of GDV1 and PfAP2-G expression16,17. Once expressed,
PfAP2-G initiates a specific transcriptional program that drives sexual
conversion and primes subsequent gametocyte differentiation5. While
the PfAP2-G-dependent transcriptional changes in sexually com-
mitted schizonts are minor, a more pronounced gene expression
signature emerges in the sexual ring stage progeny, where several
dozen genes are specifically induced or repressed compared with
asexual ring stages10,12,13,15,16,19,20.
P. falciparum sexual ring stage parasites differentiate over a period
of 10–12 days into transmission-competent mature female or male
gametocytes. Sexual ring stages (day 1) develop into spherical stage I
gametocytes (day 2) that continuously elongate into lemon-shaped
stage II (day 4), D-shaped stage III (day 6), and spindle-shaped
stage IV cells (day 8), before falciform-mature stage V gametocytes
are formed (day 10+)21,22. These morphological transitions are
linked to the gradual expansion of the inner membrane complex, an
endomembrane system underlying the parasite plasma membrane,
and the microtubule and actin cytoskeleton networks underneath
that are disassembled again at the stage IV to V transition23–27.
mRNA and protein expression profiling studies conducted mainly on
late-stage gametocytes28–32, but also on early stages31,32 or across
gametocyte maturation33,34, identified hundreds of genes and pro-
teins differentially expressed between gametocytes and asexual blood
stage parasites, or between female and male gametocytes35–38. Some
of these genes are known or predicted to be involved in biological
processes that are altered in gametocytes compared with asexual
parasites, such as host cell remodelling, energy and lipid metabolism,
cytoskeleton organisation, transcriptional regulation, chromatin
structure and translational repression5,39. During infection, stage I to
IV gametocytes are sequestered away from circulation, primarily in
the parenchyma of the bone marrow and spleen40,41. The mechan-
isms underlying gametocyte homing to and sequestration in these
extravascular niches are only poorly understood. However, the high
rigidity of stage I–IV gametocyte-infected RBCs23,42,43, conferred by
parasite-induced alterations of the RBC membrane and the under-
lying cytoskeletal networks42,44–46, appears to play a primary role in
gametocyte retention. Reversal of these modifications at the stage IV
to V transition confers increased deformability23,42–46, which is a
likely prerequisite for the release of stage V gametocytes back into
circulation41,47. Once in the bloodstream, stage V gametocytes cir-
culate and remain competent for transmission to the mosquito for
days/weeks48. The enormous transmission reservoir represented by
the hundreds of millions of infected people in endemic areas, and the
fact that almost all currently licensed antimalarial drugs, except pri-
maquine, fail to kill mature gametocytes, poses major obstacles to
malaria control and elimination efforts4,49,50.
The discovery and development of new transmission-blocking
drugs and vaccines requires a detailed functional and mechanistic
understanding of the molecular processes underlying essential
transmission stage biology and depends on robust experimental
tools for routine basic and applied research. Both prerequisites
are currently not met due to the challenges associated with the
in vitro cultivation of gametocytes, particularly the generation of
large numbers of synchronous gametocyte stages for experimental
studies: (i) P. falciparum parasites show low sexual commitment
rates (<10%), resulting in low gametocyte yields5,41; (ii) game-
tocytes are nonproliferative cells and thus are rapidly overgrown
by asexual parasites; (iii) sexual commitment occurs during each
consecutive IDC, which results in asynchronous gametocyte
populations. Current approaches to increase sexual commitment
rates in in vitro cultures are based on exposing parasites to poorly
defined stress conditions such as high parasitemia and/or nutrient
starvation (spent/conditioned medium)22,51,52. Several different
protocols relying on this strategy exist and reach sexual com-
mitment rates of 10–30%53–59. However, most of these protocols
use cumbersome experimental workflows, rely on large culture
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volumes, are expensive, difficult to reproduce, or produce asyn-
chronous gametocyte populations. Protocols employing LysoPC-
or choline-depleted minimal fatty acid medium17 achieve sexual
commitment rates in the range of 15–60%, depending on the
strain used, but growth under these nutrient-restricted conditions
reduces the number of sexually committed progeny16,17,60,61. A
recent system based on an inducible promoter-swap approach at
the pfap2-g locus triggers very high sexual conversion rates of up
to 90%; however, gametocytes produced from this line are not
infectious to mosquitoes and therefore unsuitable for research on
late-stage gametocyte biology and gametocytocidal drug
discovery19.
Here, we show that the insertion of conditional GDV1 expression
cassettes into the genome of the transmissible NF54 strain transforms
these parasites into inducible gametocyte producer (iGP) lines sui-
table for the routine mass production of infectious gametocytes.
Upon targeted induction of GDV1 expression, NF54/iGP parasites
consistently achieve sexual conversion rates of 75% and generate
synchronous gametocyte populations at high yield across all stages of
gametocytogenesis. Importantly, NF54/iGP stage V gametocytes
retain their capacity to infect female Anopheles mosquitoes and
produce sporozoites able to infect human hepatocytes. Furthermore,
by tagging the nuclear pore protein PfNUP313, we demonstrate that
further genetic engineering of NF54/iGP lines is straightforward and
a promising approach to study gametocyte biology.
Results
CRISPR/Cas9-based engineering of P. falciparum NF54 indu-
cible gametocyte producer lines based on the targeted over-
expression of GDV1. Using the FKBP destabilization domain
(DD) system for controllable protein expression62, we previously
observed that conditional overexpression of plasmid-encoded
GDV1-GFP-DD increases sexual conversion rates (SCRs) in the
3D7 reference strain16. Here, we exploited this finding in order to
generate stable and marker-free inducible gametocyte producer
(iGP) lines as tools to expedite basic and applied research on
P. falciparum gametocyte biology and transmission.
As a proof of concept, we inserted a single GDV1-GFP-DD
expression cassette into the dispensable cg6 (glp3) locus (PF3D7_
0709200)63 in 3D7 parasites using a two-plasmid CRISPR/Cas9-
based gene editing approach16 (Fig. 1a and Supplementary Fig. 1a). To
this end, we cotransfected the pHF_gC-cg6 CRISPR/Cas9 plasmid
(containing expression cassettes for the positive–negative selection
marker human dihydrofolate reductase fused to yeast cytosine
deaminase/uridyl phosphoribosyl transferase (hDHFR-yFCU), SpCas9,
and a single-guide RNA targeting the cg6 locus) and the pD_cg6_cam-
gdv1-gfp-dd donor plasmid (containing the gdv1-gfp-dd transgene
cassette flanked by cg6 homology regions) into 3D7 wild-type (wt)
parasites (Supplementary Fig. 1a). Characterisation of the resulting
transgenic 3D7/iGP mother line and three clonal populations
demonstrated that (i) the gdv1-gfp-dd transgene cassette was
successfully inserted into the cg6 locus (Fig. 1a, Supplementary
Figs. 1b–d and Supplementary Note 1), and (ii) the addition of the
stabilising ligand Shield-1 to the culture medium caused efficient
induction of GDV1-GFP-DD expression in schizonts (Fig. 1b,
Supplementary Fig. 2a and Supplementary Note 1). Importantly, IFAs
probing for the expression of the gametocyte-specific marker Pfs1664
revealed that up to 75% of parasites in the progeny of Shield-1-treated
parasites [36–44 h post invasion (hpi), generation 2, day 2 of
gametocytogenesis] represented early stage I gametocytes, compared
with only 3–5% in the control populations cultured in the absence of
Shield-1 (Fig. 1b–d, Supplementary Figs. 2b and 2c, and Supplemen-
tary Note 1).
Based on the encouraging results, we wanted to transfer the
iGP system to NF54 parasites, the strain most widely used for the
study of gametocyte biology and mosquito infection65. Unexpect-
edly, however, multiple attempts to insert the GDV1-GFP-DD
expression cassette into the cg6 locus in NF54 parasites were
unsuccessful as we did not obtain viable parasites after multiple
transfection experiments. While the reason for this failure is
unknown, we suspected that the DD-dependent degradation of
GDV1-GFP-DD may be less efficient in NF54 compared with
3D7 parasites, such that parasites harbouring the transgene
cassette would commit to sexual differentiation at an increased
rate and therefore display a slower proliferation rate. We
therefore decided to employ the glmS riboswitch approach as
an additional or alternative conditional expression system to
regulate the ectopic expression of GDV1 in NF54 parasites. The
glmS ribozyme element is usually placed within the untranslated
region of mRNAs and mediates transcript degradation when
activated by glucosamine (GlcN)66,67. We cloned two modified
versions of the pD_cg6_cam-gdv1-gfp-dd donor plasmid by
inserting a glmS ribozyme element directly downstream of the
gdv1-gfp-dd (pD_cg6_cam-gdv1-gfp-dd-glmS) or gdv1-gfp coding
sequence (pD_cg6_cam-gdv1-gfp-glmS), respectively. Cotransfec-
tion of the pBF_gC-cg6 CRISPR/Cas9 plasmid (which carries the
blasticidin deaminase (bsd) gene as a positive selection marker
instead of hdhfr) with either of the donor plasmids allowed us to
successfully select for transgenic NF54/iGP parasites in both
instances (Fig. 2a and Supplementary Figs. 3a and 3b). PCRs on
gDNA of the NF54/iGP1 line revealed complete disruption of the
cg6 locus and insertion of a single GDV1-GFP-DD-glmS
expression cassette (Supplementary Fig. 3c). However, at least a
subset of parasites in the population still contained the pBF_gC-
cg6 CRISPR/Cas9 and/or integrated donor plasmid concatamers.
Treatment with 5-fluorocytosine (5-FC) efficiently eliminated
parasites harbouring the pBF_gC-cg6 plasmid but not those
carrying integrated donor plasmid concatamers (Supplementary
Fig. 3d). The NF54/iGP2 population was free of plasmids and
showed complete disruption of the cg6 locus through insertion of
a single GDV1-GFP-glmS expression cassette (Fig. 2a and
Supplementary Fig. 3e).
Induction of GDV1-GFP-DD expression in the NF54/iGP1
line through the simultaneous removal of GlcN and addition of
Shield-1 (−GlcN/+Shield-1) produced progeny consisting of
74.8% (±4.6 SD) Pfs16-positive early stage I gametocytes (32–40
hpi in generation 2) compared with only 8.0% (±2.6 SD) in the
control population (+GlcN/−Shield-1) (Fig. 2b). Likewise,
induction of GDV1-GFP expression in the NF54/iGP2 line via
removal of GlcN (−GlcN) delivered progeny consisting of 74.1%
(±5.6 SD) early stage I gametocytes compared with only 5.7%
(±1.3 SD) in parasites cultured in the presence of GlcN (+GlcN)
(Fig. 2b). To monitor gametocyte maturation, the ring stage
progeny of induced NF54/iGP1 and NF54/iGP2 parasites was
cultured in medium containing 50 mM N-acetyl-D-glucosamine
(GlcNAc) for six consecutive days (days 1–6 of gametocytogen-
esis) to eliminate asexual parasites53,68 and was thereafter
maintained under normal culture conditions, until day 12 of
gametocyte development (Fig. 2c). Visual inspection of Giemsa-
stained blood smears prepared daily from day 4 (stage II) onward
revealed that these gametocytes differentiated in a highly
synchronous manner into stage V gametocytes within 10–12 days
(Fig. 2d and Supplementary Fig. S4). Notably, due to the high
SCRs achieved, pure stage V gametocyte populations at 4–5%
gametocytemia were consistently obtained (Fig. 2d). Hence, by
applying the glmS riboswitch approach for the conditional
overexpression of GDV1, either on its own or combined with
the FKBP/DD system, we engineered two independent marker-
free NF54/iGP lines that allow for the routine production of large
numbers of pure and synchronous NF54 gametocytes across all
stages of sexual differentiation.
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NF54/iGP gametocytes produced via GDV1 overexpression
display unaltered sex ratios and exflagellation rates. To further
validate NF54/iGP gametocytes as a valuable tool for experi-
mental research, we generated clonal NF54/iGP1 and NF54/
iGP2 populations by limiting dilution cloning. All clones were
confirmed by PCR plasmid- and marker-free and carried a
single GDV1-GFP-DD-glmS (NF54/iGP1) or GDV1-GFP-glmS
(NF54/iGP2) expression module in the cg6 locus (Supplemen-
tary Figs. 3c–e). In a preliminary experiment, induction of
ectopic GDV1 expression triggered high SCRs that were
somewhat lower compared with the corresponding mother
lines, but still reached high values of 45–65% in all clonal lines
(Supplementary Fig. 5a). Based on these results, we selected one
clone each for further characterisation (NF54/iGP1_D8 and
NF54/iGP2_E9). Sexual conversion assays performed in tripli-
cate revealed that the background SCRs under noninducing
conditions were low for both NF54/iGP1_D8 (+GlcN/−Shield-
1) (8.2% ±3.5 s.d.) and NF54/iGP2_E9 (+GlcN) (9.0% ±2.8 s.
d.), but slightly higher compared with NF54 wt parasites (2.0%
±0.5 s.d.) (Fig. 2e). This finding is not unexpected since SCRs
can vary strongly between strains and even isogenic clones10.
Alternatively, it is conceivable that leaky ectopic expression of
GDV1 in a small subset of parasites may be responsible for the
slightly elevated background SCRs. When cultured under
conditions that stabilise the gdv1-gfp-dd mRNA but not the
GDV1-GFP-DD protein (−GlcN/−Shield-1), NF54/iGP1_D8
parasites still displayed low yet slightly increased SCRs of 13.3%
(±5.5 s.d.) (Fig. 2e). This result shows that the DD-dependent
degradation of GDV1-GFP-DD is functional in NF54/iGP1
parasites, but may indeed be less efficient compared with 3D7/
iGP parasites that showed SCRs of only 3–5% in the absence of
Shield-1 (Fig. 1a and Supplementary Figs. 2c and 2e). Impor-
tantly, however, upon induction of GDV1-GFP-DD and
GDV1-GFP expression, respectively, both clones showed mas-
sively increased SCRs reaching 62.8% (±1.7 s.d.) for NF54/
iGP1_D8 (−GlcN/+Shield-1) and 72.9% (±3.7 s.d.) for NF54/
iGP2_E9 (−GlcN) (Fig. 2e). Consistent with these functional
readouts, Western blot analysis of schizont samples confirmed
the ectopic expression of GDV1 only under inducing conditions
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Fig. 1 Description of the inducible gametocyte producer line 3D7/iGP. a Schematic of the disrupted cg6 locus carrying a single inducible GDV1-GFP-DD
expression cassette. The 5′ and 3′ homology regions used for CRISPR/Cas9-based transgene insertion are shown in orange. b Schematic of the in vitro
culture protocol used to quantify sexual commitment rates (SCRs). Synchronous 3D7/iGP ring stage parasites are split at 0–16 hpi and Shield-1 is added to
one half of the population to trigger GDV1-GFP-DD expression. SCRs are quantified by determining the proportion of early stage I gametocytes in the total
iRBC progeny 36–44 hpi (day 2 of gametocytogenesis) by α-Pfs16 IFAs combined with DAPI staining. Asexual parasites are depicted in grey, sexually
committed parasites and gametocytes are depicted in purple. asS/scS, asexual/sexually committed schizont; asR/scR, asexual/sexually committed ring
stage; T, trophozoite; I–V, gametocyte stages I–V; D1–D10, days 1–10 of gametocyte maturation. Gen 1/2, generation 1/2. c α-Pfs16 IFA images illustrating
the high proportion of early gametocytes in the progeny of Shield-1-treated 3D7/iGP parasites. The white arrow highlights a Pfs16-negative schizont. Nuclei
were stained with DAPI. DIC, differential interference contrast. Images are representative of three independent experiments. Scale bar, 10 µm. d Proportion
of Pfs16-positive iRBCs (SCRs) in the progeny of 3D7/iGP treated with three different Shield-1 concentrations and the untreated control (−Shield-1) (mean
± SD, n= three biologically independent experiments; two experiments for parasites treated with 337.5 nM Shield-1). Closed circles represent data points
for individual experiments (>156 DAPI-positive cells counted per experiment).
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GDV1-GFP-DD in NF54/iGP1_D8 parasites (−GlcN/+Shield-
1) was substantially weaker compared with GDV1-GFP in
NF54/iGP2_E9 parasites (−GlcN), suggesting that GDV1-GFP-
DD expression is only moderately stabilised by Shield-1 (Fig. 2f
and Supplementary Fig. 5b). We also tested whether ectopic
expression of GDV1 occurs in gametocytes cultured in medium
lacking both GlcN and Shield-1. Whereas GDV1-GFP-DD was
not expressed in NF54/iGP1_D8 gametocytes as expected,
GDV1-GFP expression was detectable in NF54/iGP2_E9
gametocytes, but at much lower levels compared with asexual
parasites and completely abolished by addition of GlcN (Sup-
plementary Fig. 5c).
To confirm that induction of sexual commitment via ectopic
GDV1 expression has no influence on gametocyte sex ratios, we
performed IFAs on stage V gametocytes (day 10) using antibodies
against the female-specific protein Pfg37769 (Supplementary
Fig. 5d). We observed no significant difference in female/male sex
ratios between NF54/iGP2_E9 gametocytes obtained via GDV1-
GFP overexpression (−GlcN; 2.2 ±0.8 s.d.) or via induction of
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fatty acid medium (+GlcN/mFA; 1.7 ±0.3 s.d.) (p= 0.54; paired
two-tailed Student’s t test) (Fig. 2g and Supplementary Fig. 6a). The
same result was obtained from a single experiment performed using
the NF54/iGP1_D8 clone (Supplementary Fig. 6b). Together, these
results show that GDV1 overexpression has no effect on gametocyte
sex ratios, which in turn suggests that GDV1 is not involved in the
hitherto unknown sex determination pathway in P. falciparum.
Finally, as a proxy to assess gametocyte viability, we quantified male
stage V gametocyte exflagellation on days 10, 13, and 14 of
gametocytogenesis and demonstrate that both NF54/iGP1_D8 and
NF54/iGP2_E9 gametocytes exflagellated as efficiently as NF54 wt
gametocytes, and similar results were obtained for the correspond-
ing NF54/iGP mother lines (Supplementary Figs. 6c and 6d).
NF54/iGP1 and NF54/iGP2 gametocytes are infectious to
mosquitoes and produce viable sporozoites that infect human
hepatocytes. To test if NF54/iGP gametocytes retained their
capacity to undergo fertilisation and further life cycle progression
in the mosquito vector, we fed stage V gametocytes to female
Anopheles stephensi mosquitoes using Standard Mem-
brane Ffeeding Aassays (SMFAs)65,70. To this end, we triggered
sexual conversion in clones NF54/iGP1_D8 (−GlcN/+Shield-1)
and NF54/iGP2_E9 (−GlcN) as outlined in Fig. 2c, and main-
tained the ring stage progeny (day 1 of gametocytogenesis) in
culture for 14 days with daily medium changes to ensure com-
plete differentiation into mature stage V gametocytes. For each of
the two populations, separate SMFAs were performed on days 10,
13, and 14 of gametocytogenesis, and the entire experiment was
repeated with a second batch of independently produced game-
tocytes. Eight days after the feeds, 20 mosquitoes each were dis-
sected and midgut oocysts counted by microscopy. Both NF54/
iGP clones infected mosquitoes as efficiently as NF54 wt game-
tocytes on each of the three days of feeding, with 87.5–97.5%
(NF54/iGP1_D8), 92.5–100% (NF54/iGP2_E9), and 90–100%
(NF54 wt) of mosquitoes carrying midgut oocysts (Fig. 3a).
Mosquitoes infected with NF54/iGP1_D8 gametocytes con-
sistently developed about half as many oocysts compared with the
NF54 wt control, and for both of these lines the highest oocyst
numbers were observed in mosquitoes fed with day 13 gameto-
cytes (median=13 oocysts/mosquito for NF54/iGP1_D8; med-
ian=27 oocysts/mosquito for NF54 wt) (Fig. 3a). Interestingly,
NF54/iGP2_E9 gametocytes achieved even higher oocyst inten-
sities compared with NF54 wt gametocytes and were most
infectious on day 13 (median= 37 oocysts/mosquito) and day 14
(median= 47 oocysts/mosquito) (Fig. 3a). Gametocytes of the
NF54/iGP1 and NF54/iGP2 mother lines were also infectious to
mosquitoes. While infections with NF54/iGP1 gametocytes
resulted in infection rates and oocyst intensities similar to those
obtained with the clonal NF54/iGP1_D8 line, NF54/iGP2 game-
tocytes infected fewer mosquitoes and developed fewer oocysts on
all three feeding days (Supplementary Fig. 7a).
To assess sporozoite production and viability, salivary gland
sporozoites were isolated on day 17 post infection from mosquitoes
infected with day 14 gametocytes. We observed higher salivary gland
sporozoite intensities in mosquitoes infected with clones NF54/
iGP1_D8 (mean=69,510 sporozoites/mosquito) and NF54/iGP2_E9
(mean=101,692 sporozoites/mosquito) (Fig. 3b), as well as the NF54/
iGP1 mother line (mean=69,657 sporozoites/mosquito) (Supplemen-
tary Fig. 7b), compared with the NF54 wt control (mean=24,676-
sporozoites/mosquito) (Fig. 3b). Due to the low number of midgut
oocysts in mosquitoes infected with NF54/iGP2 mother line
gametocytes, strongly reduced sporozoite intensities were observed
in these infections (mean=6,265 sporozoites/mosquito) (Supplemen-
tary Fig. 7b). When normalised to the mean oocyst intensities, the
numbers of sporozoites per oocyst were about twice as high for NF54/
iGP1_D8 (mean=4065 sporozoites/oocyst) and NF54/iGP1
(mean=3440 sporozoites/oocyst) compared with NF54/iGP2_E9
(mean=1930 sporozoites/oocyst), NF54/iGP2 (mean=
1989 sporozoites/oocyst), and NF54 wt (mean=1552 sporozoites/
oocyst) (Fig. 3b and Supplementary Fig. 7b). To assess sporozoite
infectivity, we conducted a hepatocyte infection assay using primary
human hepatocytes. Confocal fluorescence microscopy analysis of
cells stained with antibodies against PfHSP70 (parasite cytosol) and
PfEXP2 (parasitophorous vacuolar membrane) showed that NF54/
iGP1_D8, NF54/iGP2_E9, and NF54/iGP1 sporozoites successfully
invaded hepatocytes and underwent intrahepatocytic maturation
comparable with the NF54 wt control, at least until day 5 post
infection (note that the low number of sporozoites isolated from
NF54/iGP2-infected mosquitoes were insufficient to perform
hepatocyte-invasion assays) (Fig. 3c and Supplementary Fig. 7c).
Due to the low infection rates observed for all lines in this particular
experiment, however, we were unable to quantify hepatocyte
infection. Noteworthy, for both clones, ectopic GDV1 expression
was undetectable in oocysts and salivary gland sporozoites by live-cell
fluorescence microscopy, or in liver-stage parasites by IFAs using
α-GFP antibodies (Fig. 3c and Supplementary Fig. 7c).
Fig. 2 Description of the inducible gametocyte producer lines NF54/iGP1 and NF54/iGP2. a Schematics of the disrupted cg6 locus carrying a single
inducible GDV1-GFP-DD-glmS or GDV1-GFP-glmS expression cassette in NF54/iGP1 or NF54/iGP2, respectively. The 5′ and 3′ homology regions used for
CRISPR/Cas9-based transgene insertion are shown in orange. b Proportion of Pfs16-positive iRBCs (SCRs) in the progeny of NF54/iGP1 and NF54/iGP2
cultured under noninducing or inducing conditions (mean ± SD, n= three biologically independent experiments). Closed circles represent data points for
individual experiments (≥391 DAPI-positive cells counted per experiment). c Schematic of the in vitro culture protocol used to obtain pure NF54/
iGP2 stage V gametocyte populations. GlcN is removed from the culture medium of synchronous ring stage parasites at 0–16 hpi to trigger expression of
GDV1-GFP. After schizont rupture and merozoite invasion, gametocyte maturation proceeds for >10 days. Asexual parasites are depicted in grey, sexually
committed parasites and gametocytes are depicted in purple. asS/scS, asexual/sexually committed schizont; asR/scR, asexual/sexually committed ring
stage; T, trophozoite; I–V, gametocyte stages I–V; D1–D10, days 1–10 of gametocyte maturation. Gen 1/2, generation 1/2. d Images of Giemsa-stained
NF54/iGP2 gametocyte cultures, acquired on day 1 (asexual/sexually committed ring stages), day 6 (stage III gametocytes), and day 11 (stage V
gametocytes). Images are representative of three independent experiments. Scale bar, 20 µm. Parasitemias determined from three independent induction
experiments are shown on the right (≥2068 RBCs counted per experiment). e Proportion of Pfs16-positive iRBCs (SCRs) in the progeny of NF54/iGP1_D8
and NF54/iGP2_E9 parasites cultured under noninducing or inducing conditions and of NF54 wt control parasites (mean ± SD, n= three biologically
independent experiments). Closed circles represent data points for individual experiments (≥143 DAPI-positive cells counted per experiment). f Western
blot showing expression of GDV1-GFP (MW=99.1 kDa) and GDV1-GFP-DD (MW=111.3 kDa) in NF54/iGP2_E9 and NF54/iGP1_D8 schizonts (34–42 hpi),
respectively. PfHP1 (MW= 31 kDa) served as a control to compare the relative numbers of nuclei loaded per lane. The results are representative of two
independent experiments. g Sex ratios of NF54/iGP2_E9 stage V gametocytes obtained via GDV1-GFP overexpression (−GlcN) or via induction of sexual
commitment using mFA medium (+GlcN/mFA), as quantified from α-Pfg377 IFAs (mean ± SD, n= three biologically independent experiments). Closed
circles represent data points for individual experiments (≥192 gametocytes scored per experiment). Sex ratios were compared using a paired two-tailed
Student’s t test (p value indicated above the graph).
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Together, these results demonstrate that the NF54/iGP1_D8
and NF54/iGP2_E9 clones, and the NF54/iGP1 mother line,
complete their life cycle in the mosquito vector as efficiently as
NF54 wt parasites and produce sporozoites able to infect and
mature within human liver cells.
Further genetic manipulation of NF54/iGP parasites for the
targeted investigation of gametocyte biology. To explore NF54/
iGP parasites as a tool to study specific aspects of gametocyte
biology, we engineered NF54/iGP2 parasites expressing a
mScarlet-tagged version of the nuclear pore protein PfNUP313
(Supplementary Fig. 8). Nuclear pores are large macromolecular
complexes that are embedded in the nuclear envelope and consist
of approximately 30 different nucleoporins (NUPs) (each present
in multiple copies)71. Nuclear pore complexes (NPCs) act as
essential gateways for molecular transport into and out of the
nucleus and play additional crucial roles in the regulation of gene
expression and genome organisation71,72.
In malaria parasites, nuclear pores have hardly been studied
and only six NUPs have been identified so far73–77, of which four
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(PF3D7_0905100)77, PfNUP313 (PF3D7_1446500)73, and
PfSEC13 (PF3D7_1230700)76]. We were interested in visualising
nuclear pores in gametocytes for two reasons. First, the number
and distribution of NPCs within the nuclear envelope of asexual
parasites changes dramatically as they progress through the
IDC74,78,79. The functional relevance of these dynamic NPC
expression patterns is currently unknown, but may be linked to
regulatory strategies of stage-specific gene expression and/or the
coordination of nuclear segregation during schizogony78. We
therefore wished to learn how NPC abundance and localisation
compares in differentiating gametocytes. Second, early studies
investigating gametocyte morphology at the ultrastructural level
suggested a pronounced nuclear dimorphism between female and
male gametocytes26,80, but this has not been further explored in
any great detail. To revisit this intriguing observation, we wanted
to visualise the outer confines of the parasite nucleus throughout
gametocytogenesis by fluorescence microscopy. Since P. falci-
parum lacks homologues of known nuclear envelope-associated
proteins such as lamin, we used the NPC as a surrogate marker
for the nuclear membrane.
To obtain NF54/iGP2_NUP313-mSc parasites, we cotrans-
fected the pBF_gC-nup313 CRISPR/Cas9 plasmid and the
pD_nup313-mScarlet donor plasmid into the NF54/iGP2 line
(Supplementary Fig. 8). Transgenic parasites were successfully
selected on BSD-S-HCl and PCRs on gDNA confirmed correct
editing of the nup313 gene and absence of parasites carrying the
wt locus (Supplementary Fig. 8). Validation of the NF54/
iGP2_NUP313-mSc line by live-cell fluorescence imaging verified
the expected localisation of nuclear pores across the different IDC
stages as determined in previous studies74,78,79 (Fig. 4a).
PfNUP313-mScarlet localised to a single region adjacent to
the DAPI-stained area in merozoites and early ring stages. The
increased number and even distribution of NPCs within the
nuclear envelope in trophozoites and early schizonts was reflected
by a circular perinuclear pattern of PfNUP313-mScarlet foci
directly adjoining the genetic material. In late schizonts, the
number of PfNUP313-mScarlet signals decreased again to one or
two per nucleus. To assess PfNUP313-mScarlet localisation in
gametocytes, we induced sexual commitment in NF54/
iGP2_NUP313-mSc parasites according to the protocol outlined
in Fig. 2c and performed live-cell fluorescence imaging for all five
gametocyte stages. As shown in Fig. 4b, PfNUP313-mScarlet
signals were abundant and surrounded the often elongated area of
nuclear DNA in a dot-like fashion in all five gametocyte stages,
similar to the localisation pattern observed in trophozoites
(Fig. 4a). However, in stage II to V gametocytes, the NPC signals
frequently stretched away from bulk chromatin, suggestive of
rounded expansions (pink arrowheads) and narrow lateral
extensions (yellow arrowheads) of the nuclear envelope that
sometimes reached close to the cellular poles (Figs. 4b and 5,
Supplementary Fig. 9). Primarily in late-stage gametocytes, we
also observed nuclei with two clearly separate PfNUP313-
delineated regions, of which either both (white arrowheads) or
only one (blue arrowhead) contained genetic material detectable
by Hoechst staining (Fig. 5). In summary, our findings show that
gametocyte nuclei contain a similar or even higher density of
NPCs compared with trophozoites, undergo profound changes in
nuclear shape and size, and often contain regions of low
chromatin density.
Discussion
Here, we engineered robust inducible gametocyte producer (iGP)
lines that will allow investigating gametocyte biology with a similar
level of routine, depth, and detail hitherto reserved only for the
study of asexual blood stage parasites. We achieved this by inserting
a single conditional GDV1 expression cassette into the genomes of
the 3D7 and NF54 strains. In these parasites, a single pulse of
ectopic GDV1 overexpression in trophozoites and schizonts is
sufficient to induce sexual commitment in a high proportion of
parasites. Importantly, this approach mimics the natural process of
GDV1-dependent sexual conversion. GDV1 is a specific and
essential activator of PfAP2-G expression, and induction of endo-
genous GDV1 expression in trophozoites and schizonts is part of
the inherent pathway of sexual commitment16,18,81. Furthermore,
we have previously shown that the temporary activation of ectopic
GDV1 expression triggers the typical PfAP2-G-dependent tran-
scriptional cascade of sexual conversion and early gametocyte dif-
ferentiation and has no effect on the transcription of other genes16.
The iGP lines described in this study overcome the limitations
of current protocols used for the bulk preparation of gametocytes.
First, induction of sexual commitment is entirely independent of
cumbersome and unreliable culture-handling protocols and only
requires adding Shield-1 and/or removing GlcN from the culture
medium to induce ectopic GDV1 expression. Second, the targeted
induction of ectopic GDV1 expression triggers consistent sexual
commitment rates of up to 75%, which allows generating large
numbers of gametocytes even from small culture volumes. Third,
sexual commitment is induced in a synchronous population of
asexual blood stage parasites, which leads to synchronous sexual
differentiation in the progeny and therefore facilitates preparing
stage-specific gametocyte populations across gametocyte
maturation. Fourth, gametocyte synchronicity and yield are
highly reproducible between experiments; starting with approxi-
mately 0.75 × 107 ring-stage parasites in the commitment cycle
(5% haematocrit, 1.5% parasitemia) routinely delivers up to 2 ×
108 stage V gametocytes per 10 ml of culture in a single induction
experiment (Fig. 6), which increases gametocyte yields by at least
one order of magnitude compared with previous reports53,58,82.
Because gametocyte production can be induced once every sec-
ond day from a synchronous asexual feeder culture, the iGP lines
Fig. 3 NF54/iGP1_D8 and NF54/iGP2_E9 gametocytes complete their life cycle in the mosquito vector and produce infectious sporozoites. a NF54/
iGP1_D8 (orange), NF54/iGP2_E9 (blue), and NF54 wt control stage V gametocytes (green) were fed to female Anopheles stephensimosquitoes on day 10,
13, and 14 of gametocytogenesis in two independent SMFA experiments. The violin plots show the distribution of the number of oocysts detected in each of
the 20 mosquitoes dissected per feed, with open circles and triangles representing data from SMFA replicates 1 and 2, respectively (left y axis). The median
(thick red line) and upper and lower quartiles (thin red lines) are indicated. Closed red circles represent the mean oocyst prevalence (number of infected
mosquitoes) determined for each of the two replicate feeds (right y axis). NF54 wt day 10 and day 13 gametocytes were only included in SMFA replicate 1,
and for SMFA replicate 2, only 10 mosquitoes infected with NF54 wt day 14 gametocytes have been dissected. b Mean number of salivary gland
sporozoites per oocyst (left y axis) and per mosquito (closed red circles; right y axis) 17 days after infection with NF54/iGP1_D8 (orange), NF54/iGP2_E9
(blue), and NF54 wt control day 14 gametocytes (green) (SMFA replicate 2 data). Values represent the results from a single experiment (≥26 mosquitoes
dissected per infected batch). c Confocal microscopy IFA images showing intracellular parasites after infection of primary human hepatocytes with NF54/
iGP1_D8, NF54/iGP2_E9, and NF54 wt control sporozoites. Parasites were stained with α-PfHSP70 (cytosol; red) and α-PfEXP2 antibodies
(parasitophorous vacuolar membrane; purple). α-GFP antibodies were used to test for potential ectopic expression of GDV1 in liver stages. Nuclei were
stained with DAPI. Images are representative of a single experiment. Scale bar, 18 µm.
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provide a constant rich source of synchronous gametocyte
populations for experimental studies.
Similar to the recently developed 3D7/E5ind line that uses a con-
ditional promoter-swap approach to induce PfAP2-G expression19,
the 3D7/iGP line produces exflagellation-defective male stage V
gametocytes and is therefore of limited value for the investigation of
late-stage gametocyte biology and gametocytocidal drug discovery.
However, 3D7/iGP parasites still provide a useful tool to dissect the
molecular events linked to sexual conversion and early gametocyte
differentiation. The 3D7/E5ind line is superior in this regard as it
displays virtually zero background sexual commitment and achieves
sexual conversion rates of up to 90% upon induction of PfAP2-G
expression, which allows identifying molecular signatures of sexually
committed parasites with high precision19. 3D7/iGP parasites will be
useful to complement such studies and to investigate the mechanisms
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In contrast to the above-mentioned cell lines, NF54/iGP gameto-
cytes are infectious to mosquitoes. Our comprehensive characterisa-
tion of NF54/iGP1_D8 and NF54/iGP2_E9 validated these clonal
lines as most promising tools for future research. Both clones infect
mosquitoes and produce oocysts and infectious salivary gland spor-
ozoites as efficiently as NF54 wt parasites. Furthermore, the mosquito
infection rates and oocyst/sporozoite intensities achieved in this study
are consistent with SMFA outcomes usually obtained with NF54 wt
gametocytes83–85. Moreover, NF54/iGP1_D8 and NF54/iGP2_E9
parasites are confirmed plasmid- and marker-free and therefore allow
further rounds of genetic manipulation using any of the three
drug resistance markers routinely used for selection of transgenic
parasites (hdhfr, bsd, yeast dihydroorotate dehydrogenase). Manip-
ulating genes in NF54/iGP parasites provides the great advantage that
the study of gene and protein function by phenotypic, cell biological,
biochemical, or structural analyses can routinely be performed not
only in asexual blood stage parasites but readily also in a large
number of isogenic gametocytes. Owing to these favourable prop-
erties, NF54/iGP1_D8 and NF54/iGP2_E9 parasites offer numerous
opportunities for basic and applied malaria transmission stage
research (Fig. 6; see also Supplementary Table 2 for a comparison of
both clones and recommendations for their use in future research).
For instance, NF54/iGP parasites will facilitate the targeted dissection
of molecular mechanisms underlying the specific biology of game-
tocytes. They will also lend themselves for time-resolved high-
throughput profiling experiments to generate comprehensive tran-
scriptomics, (phospho-)proteomics, epigenomics and metabolomics
reference and experimental datasets for each stage of gametocyte
development. Indeed, NF54/iGP2 parasites have recently been used
for in-depth comparative complexome profiling experiments,
revealing crucial insight into the differential abundance and com-
position of mitochondrial respiratory chain complexes between
asexual blood stage parasites and gametocytes86. Importantly, NF54/
iGP parasites will also simplify and streamline high-throughput
drug screening campaigns to identify gametocytocidal compounds
and support the preclinical development of transmission-blocking
drugs and vaccines. NF54/iGP gametocytes may further provide a
reliable resource for research on mosquito and liver stage parasites
and for the optimisation of protocols aiming to produce zygotes,
ookinetes, oocysts, and sporozoites in vitro87–89 (Fig. 6). Transferring
the iGP approach to other P. falciparum strains could facilitate the
systematic analysis of potential strain-dependent differences in
gametocyte biology, sensitivity to antimalarial drugs, infectiousness to
mosquitoes, or the capacity to undergo cross-fertilisation.
We illustrated the feasibility of subjecting NF54/iGP parasites to
a second round of genetic engineering by tagging the nuclear pore
component PfNUP313 in the NF54/iGP2 line. Our fluorescence
microscopy data demonstrate marked differences in NPC abun-
dance and distribution in the nuclear envelope, as well as in
nuclear morphology between asexual blood stage parasites and
gametocytes. The results obtained from asexual parasites recapi-
tulate previous findings obtained by high-resolution
microscopy74,78,79. These studies showed that merozoites and
ring stage parasites possess only three to seven nuclear pores that
are closely clustered in one region of the nuclear membrane. As
ring stage parasites develop into trophozoites, the number of
NPCs increases and up to 60 NPCs are evenly distributed
throughout the nuclear envelope. During schizogony, the number
of pores per nucleus decreases with increasing numbers of nuclei
formed, such that in late schizonts, each nucleus of the developing
merozoites again possesses only a small number of clustered
nuclear pores74,78,79. In contrast, we found that gametocyte nuclei
contain a stable and relatively high number of evenly distributed
NPCs throughout all stages of gametocyte development, similar to
what is observed for trophozoite nuclei. These observations are
consistent with the open chromatin conformation and high
transcriptional activity observed in both life cycle stages90–92 and
are suggestive of a high demand for nucleocytoplasmic shuttling
during periods of growth. Importantly, because NPCs serve as a
surrogate marker delineating the nuclear envelope, our results also
allow us to conclude that the nucleus in stage II to V gametocytes
(i) undergoes marked morphological transformations reflected in
narrow lateral extensions along the longitudinal axis of the
gametocyte or rounded expansions of the nuclear envelope; and
(ii) is frequently considerably larger than what might be extra-
polated from the Hoechst-stained bulk of genetic material, in line
with observations made in P. berghei gametocytes75. In some late-
stage gametocytes, we even observed two distinct NPC-
demarcated regions, of which one or both stained positive with
Hoechst. Together, these data suggest that nuclear reorganisation
and functional genome compartmentalisation plays an important
role in transcriptional reprogramming during gametocytogenesis
and/or in the preparation for genome endoreplication and ferti-
lisation in male and female stage V gametocytes, respectively.
Interestingly, the results obtained from transmission electron
microscopy studies suggested that the nuclei of female and male
gametocytes differ markedly both in size and shape, with the
female nucleus being generally oval-shaped and comparably small
and the male nucleus appearing substantially larger with a lobular
shape and distending toward the poles of the gametocyte26,80. It is
therefore tempting to speculate that the cells containing enlarged
and irregularly shaped nuclei detected in our study may primarily
represent male gametocytes. However, although differential hae-
mozoin crystal distribution has been proposed as a diagnostic
feature to distinguish between the two sexes (dispersed in males,
clustered in females)21,26, we observed ambiguous pigment pat-
terns and irregular nuclear shapes in gametocytes with clustered or
dispersed haemozoin distribution alike (Figs. 4b and 5 and Sup-
plementary Fig. 9), suggesting that the nucleus undergoes marked
transformations in both male and female gametocytes. Notwith-
standing this uncertainty, our analysis of NF54/iGP2_NUP313-
mSc parasites revealed new insight into the intriguing morpho-
logical features of gametocyte nuclei based on standard fluores-
cence microscopy and provides an excellent starting point for
further detailed cytological and functional investigations of
nuclear biology in P. falciparum transmission stages.
Fig. 4 Visualisation of nuclear pore distribution in NF54/iGP2_NUP313-mSc asexual blood stage parasites and gametocytes. a Schematic maps of the
disrupted cg6 locus carrying a single inducible GDV1-GFP-glmS expression cassette and the tagged nup313 locus in the double-transgenic NF54/
iGP2_NUP313-mSc line are shown on top. The 5′ and 3′ homology regions used for CRISPR/Cas9-based genome editing are shown in orange. Live-cell
fluorescence microscopy images showing the localisation of NUP313-mScarlet (red) in asexual blood stage parasites. ER/LR, early/late ring stage; T,
trophozoite; ES/LS, early/late schizont; M, merozoite. DIC, differential interference contrast. Nuclei were stained with DAPI. Images are representative of
three biologically independent experiments. Scale bar, 5 µm. White frames refer to the magnified view presented in the rightmost images (scale bar, 2 µm).
b Live-cell fluorescence microscopy images showing the localisation of NUP313-mScarlet (red) in stage I to V gametocytes. Lateral extensions of the
nucleus away from Hoechst-stained bulk chromatin are highlighted by yellow arrowheads. I–V, stage I to V gametocytes. DIC, differential interference
contrast. Nuclei were stained with Hoechst (blue). Images are representative of four biologically independent experiments. Scale bar, 5 µm. White frames
refer to the magnified view presented in the rightmost images (scale bar, 2 µm).
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Fig. 5 Nuclei in stage II–V gametocytes undergo marked morphological transformations. Schematic maps of the disrupted cg6 locus carrying a single
inducible GDV1-GFP-glmS expression cassette and the tagged nup313 locus in double-transgenic NF54/iGP2_NUP313-mSc line are shown on top. The 5′
and 3′ homology regions used for CRISPR/Cas9-based genome editing are shown in orange. Live-cell fluorescence microscopy images showing the
localisation of NUP313-mScarlet (red) in stage II to V gametocytes. Lateral extensions (yellow arrowheads) or rounded expansions (pink arrowheads) of
the nucleus away from Hoechst-stained bulk chromatin and separate NUP313-mScarlet-delineated regions enclosing (white arrowheads) or devoid of
Hoechst-stained bulk chromatin (blue arrowhead) are highlighted. II–V, stage II to V gametocytes. DIC, differential interference contrast. Nuclei were
stained with Hoechst. Images are representative of four biologically independent experiments. Scale bar, 5 µm. White frames refer to the magnified view
presented in the rightmost images (scale bar, 2 µm).
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In summary, we engineered marker-free inducible gametocyte
producer lines that facilitate the routine mass production of
synchronous gametocyte populations using a simple and repro-
ducible experimental setup. We demonstrate that NF54/iGP1_D8
and NF54/iGP2_E9 parasites complete their life cycle in the
mosquito vector and produce sporozoites that are infectious to
human hepatocytes. We also showed that further genetic engi-
neering of NF54/iGP parasites is straightforward. Hence, we
believe the iGP approach developed in this study will become an
invaluable and broadly applicable tool for fundamental, applied
and translational research in the field of malaria-transmission
biology.
Methods
Parasite culture. P. falciparum 3D7 parasites were cultured using AB+ or 0+
human RBCs at 5% haematocrit and RPMI 1640 medium supplemented with 25
mM HEPES, 100 mM hypoxanthine, and 24 mM sodium bicarbonate and com-
plemented with 0.5% Albumax II (Life Technologies). NF54 parasites were cultured
with 10% AB+ human serum instead of 0.5% Albumax II. Growth medium was
replaced daily. Intraerythrocytic growth synchronisation was achieved using
repeated sorbitol treatments93. The NF54/iGP1, NF54/iGP2, and NF54/
iGP2_NUP-mScarlet lines were cultured in the presence of 2.5 mM D-(+)-gluco-
samine hydrochloride (GlcN) to maintain glmS ribozyme activity during routine
parasite propagation.
Transfection constructs for CRISPR/Cas9-based gene editing. Inducible gdv1
transgene expression cassettes were inserted into the cg6 (glp3) locus
(PF3D7_0709200) of 3D7 and NF54 wt parasites by cotransfecting 50 μg each of a
CRISPR/Cas9 transfection vector and a donor plasmid delivering the transgene
cassette. 3D7/iGP1 was obtained by cotransfecting pHF_gC-cg6 and pD_cg6_cam-
gdv1-gfp-dd into 3D7 wt parasites. NF54/iGP1 was obtained by cotransfecting
pBF_gC-cg6 and pD_cg6_cam-gdv1-gfp-dd-glmS into NF54 wt parasites. NF54/
iGP2 was obtained by cotransfecting pBF_gC-cg6 and pD_cg6_cam-gdv1-gfp-glmS
into NF54 wt parasites. NF54/iGP2_NUP313mSc was obtained by cotransfecting
pBF_gC-nup313 and pD_nup313-mScarlet into NF54/iGP2 parasites. All trans-
fection plasmids cloned in this study are derivatives of the original pHF_gC/
pBF_gC CRISPR/Cas9 and pD donor plasmids published by Filarsky and
colleagues16 and are schematically displayed in Supplementary Figs. 1, 3 and 8.
The pHF_gC-cg6 CRISPR/Cas9 plasmid was generated by T4 DNA ligase-
dependent insertion of annealed complementary oligonucleotides (11 F, 11 R)
encoding the single-guide RNA (sgRNA) target sequence sgt_cg6 along with
compatible single-stranded overhangs into BsaI-digested pHF_gC16. The sgt_cg6
target sequence (gcacaaatataaattaaatt) is positioned 24–44 bp downstream of the
start codon of the cg6 (glp3) gene and has been designed using CHOPCHOP94.
pBF_gC-cg6 was generated in the same manner using the pBF_gC vector16.
The pD_cg6_cam-gdv1-gfp-dd donor plasmid was generated by Gibson
assembly95 of five PCR fragments encoding (1) the P. falciparum calmodulin (cam)
promoter followed by a gdv1-gfp-dd fusion gene (amplified from pHcam-gdv1-gfp-
dd16 using primers 1 F and 1 R), (2) the P. berghei dihydrofolate reductase-
thymidylate synthase (pbdhfr-ts) terminator sequence (amplified from the pH_gC
vector16 using primers 2 F and 2 R), (3) a 387 bp cg6 3′ homology region (HR)
spanning bps 392–778 of the cg6 coding sequence (amplified from 3D7 gDNA
using primers 3 F and 3 R), (4) the plasmid backbone (amplified from pUC19 using
primers 4 F and 4 R), and (5) a 276-bp cg6 5′ HR spanning bps −343 to −68
upstream of the cg6 gene (amplified from 3D7 gDNA using primers 5 F and 5 R).
The pD_cg6_cam-gdv1-gfp-dd-glmS donor plasmid has been cloned by Gibson
assembly using three fragments, namely (1) the EcoRI/AgeI fragment of
pD_cg6_cam-gdv1-gfp-dd encoding part of the cg6 3′ HR (bps 482–778 of the cg6
coding sequence), the vector backbone, the cg6 5′ HR, the cam promoter, the gdv1
gene, and bps 1–715 of the gfp coding sequence; (2) a PCR fragment encoding bps
699–714 of the gfp coding sequence followed by the dd and glmS-246 sequence
(amplified from pD_ap2g-gfp-dd-glmS16 using primers 7 F and 7 R); (3) a PCR
fragment encompassing the pbdhfr-ts terminator sequence and part of the cg6 3′
HR (spanning bps 392–501 of the cg6 coding sequence) (amplified from
pD_cg6_cam-gdv1-gfp-dd using primers 8 F and 8 R).
The pD_cg6_cam-gdv1-gfp-glmS vector was generated through Gibson assembly
of two PCR fragments representing (1) the pbdhfr-ts terminator sequence, the cg6 3’
HR, the vector backbone, the cg6 5′ HR, the cam promoter, the gdv1 gene, and bps
1–714 of the gfp coding sequence followed by a TAA stop codon (amplified from
pD_cg6_cam-gdv1-gfp-dd-glmS using primers 9 F and 9 R); and (2) the glmS-246
sequence (amplified from pD_ap2g-gfp-dd-glmS16 using primers 10 F and 10 R).
To tag the nucleoporin NUP313 (PF3D7_1446500) with mScarlet96 in NF54/
iGP2 parasites, the following CRISPR/Cas9 and donor plasmids were cloned. The
pBF_gC-nup313 vector was generated by T4 DNA ligase-dependent insertion of
annealed complementary oligonucleotides (18 F, 18 R) encoding the sgRNA target
sequence sgt-nup313 along with compatible single-stranded overhangs into BsaI-
digested pBF_gC16. The sgt_nup313 target sequence (gcactttgtagagataagta) is
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Fig. 6 Scheme depicting the simple induction protocol for the routine mass production of NF54/iGP gametocytes and potential applications for future
research. Addition of Shield-1/removal of GlcN (NF54/iGP1) or removal of GlcN (NF54/iGP2) from a synchronous ring stage culture triggers sexual
commitment in trophozoites and produces progeny consisting of up to 75% sexual ring stage parasites. Addition of 50mM GlcNAc to the culture medium
for the next six days eliminates the remaining asexual parasites. Expected numbers of parasite-infected RBCs (#) and percent parasitaemia (% P) of total
(black letters), asexual (grey letters), and sexual (red letters) parasites in the progeny routinely obtained from a 10ml culture at 5% haematocrit (HC) and
1.5% starting parasitaemia are indicated. Asexual parasites are depicted in grey, sexually committed parasites and gametocytes are depicted in purple
(females) and green (males). asS/scS asexual/sexually committed schizont, asR/scR asexual/sexually committed ring stage, T trophozoite, I–V
gametocyte stages I–V, D1–D10 days 1–10 of gametocyte maturation, G gametes, Z zygote, Ok ookinete, Oc oocyst, Sp sporozoites, hepS intrahepatic
schizont. Possible applications of NF54/iGP lines for basic, applied, and translational research on P. falciparum gametocytes and mosquito-stage parasites
are listed below the schematic.
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positioned at 91–110 bp downstream of the nup313 coding sequence. The
pD_nup313-mScarlet donor vector is a result of Gibson assembly of five PCR
fragments encompassing (1) a 941-bp nup313 5′ HR spanning bps 8063–9003 of
the nup313 coding sequence (amplified from NF54 gDNA using primers 13 F and
13 R), (2) the mScarlet gene (amplified from a P. falciparum codon-adjusted
synthetic sequence (Genscript) (Supplementary Fig. 10) using primers 14 F and 14
R), (3) the P. falciparum histidine-rich protein 2 (hrp2) terminator sequence
(amplified from pBF_gC with primers 15 F and 15 R), (4) a 1000 bp nup313 3′ HR
spanning the region 90–1089 bp downstream of the nup313 coding sequence
(amplified from NF54 gDNA using primers 16 F and 16 R), and (5) the vector
backbone amplified from pBF_gC using primers 17 F and 17 R. All oligonucleotide
sequences used for cloning and Sanger sequencing are provided in Supplementary
Table 1.
Parasite transfection and selection of transgenic lines. Parasites were trans-
fected and gene-edited parasites selected as described by Filarsky and colleagues16.
Briefly, RBCs derived from 5ml of a synchronous ring stage culture (5–10%
parasitaemia) were co-transfected with the matching pair of CRISPR/Cas9 and
donor plasmids (50 µg each) using a Bio-Rad Gene Pulser Xcell Electroporation
System (single pulse, 310 V, 250 µF). Twenty-four hours after transfection, 3D7/
iGP parasites were selected with 5 nM WR99210 (WR) for the following six days
and NF54/iGP1, NF54/iGP2, and NF54/iGP2_NUP313-mSc parasites were selec-
ted with 2.5 µg/ml blasticidin-S-HCl (BSD) for the following eleven days. There-
after, all transfected parasites were cultured in the absence of drug pressure, until
stably propagating populations were established. PCR on gDNA was performed to
confirm proper genome editing and absence of plasmid DNA. The 3D7/iGP and
NF54/iGP1 lines, which still retained the pHF_gC or pBF_gC CRISPR/Cas9
plasmids expressing the negative selection marker yFCU fused to hDHFR or BSD
deaminase, respectively, were treated with 40 µM 5-fluorocytosine (5-FC) to obtain
plasmid-free populations. 3D7/iGP, NF54/iGP1, and NF54/iGP2 lines were cloned
out by limiting dilution using plaque assays97. All oligonucleotide sequences used
for PCR on parasite gDNA and plasmid DNA are provided in Supplementary
Table 1.
Immunofluorescence assays. α-GFP and α-Pfs16 IFAs were performed with
methanol-fixed cells using mouse mAbs α-GFP (1:200) (Roche, #11814460001) and
α-Pfs16 (1:500)98 primary antibodies, and Alexa Fluor 488 goat α-mouse IgG
secondary antibody (1:200) (Invitrogen, #A-11001). Staining of DNA and
mounting of IFA slides was performed using Vectashield with DAPI (Vector
Laboratories, #H-1200). Microscopy was performed using a Leica DM 5000B
microscope with a Leica DFC 345 FX camera using a 63x immersion oil objective
(total magnification= 1008x). All images were acquired via the Leica Application
Suite software (version LAS 4.9.0) and processed using Adobe Photoshop CC with
identical settings.
α-Pfg377 IFAs were performed with stage V gametocytes (day 10) fixed in
methanol–acetone (60:40) using rabbit α-Pfg377 antibodies (1:1,000)69 and Alexa
Fluor 568 goat α-rabbit IgG (1:250) (Invitrogen, #A-11011). Nuclear DNA was
stained during slide preparation with Vectashield containing DAPI (Vector
Laboratories, #H-1200-10). Microscopy was performed using a Leica DM 5000B
microscope with a Leica K5 camera using a 40x objective (total magnification=
400x). All images were acquired via the Leica Application Suite software (version
LAS X) and processed using Fiji with identical settings.
IFAs on infected hepatocytes were performed on methanol-fixed cells with
rabbit α-PfHsp70 (1:75) (StressMarq Biosciences, SPC-186), mouse α-Exp2
(1:1000) (The European Malaria Reagent Repository, 7.7), and chicken α-GFP
(1:1000) (Invitrogen, #A10262) as primary antibodies and Alexa Fluor Plus 488
goat α-chicken IgY (Invitrogen, #A32931), Alexa Fluor 594 goat α-rabbit IgG
(Invitrogen, #A32740), and Alexa Fluor 647 goat α-mouse IgG (Invitrogen,
#A32728) secondary antibodies (all 1:400). All IFAs were performed in 96-well
black/clear flat-bottom imaging microplates and DNA was stained with DAPI
(Vector Laboratories, #H-1200). Confocal microscopy on infected hepatocytes was
performed using a Zeiss LSM880 microscope with Airyscan using a 63x immersion
oil objective (total magnification= 1008x). All images were acquired via the Zen
Black software (version 14.0.18.201) and processed using Fiji with identical
settings.
Live-cell fluorescence microscopy. To perform live-cell fluorescence imaging of
NUP313-mScarlet presented in Fig. 4 and Supplementary Fig. 9, asexual blood
stages were stained with 1 µg/mL DAPI (Biomol) in RPMI and gametocytes were
stained with 4.5 µg/mL Hoechst33342 (Chemodex) in PBS at 37 °C for 15 min.
Stained cells were pelleted at 1000 g for 1 min and the pellet resuspended in an
equal volume of supernatant. About 10 µL of the sample were placed on a
microscopy slide and covered with a cover slip. Fluorescence microscopy images
were acquired with a Leica DM6 B microscope equipped with Leica DFC9000 GT
camera using a 100x immersion oil objective (total magnification= 1000x). Filter
block settings: mScarlet (Ex. 542–585 nm; Em. 604–644 nm), DAPI/Hoechst (Ex.
325–375; Em. 435–485). All images were acquired with the Leica Application Suite
X software (LAS X) and processed using Adobe Photoshop CS2 with identical
settings.
To perform live-cell fluorescence imaging of NUP313-mScarlet presented in
Fig. 5, gametocytes were stained with 4.5 µg/mL Hoechst33342 (Sigma–Aldrich) in
PBS at 37 °C for 20 min. Stained cells were pelleted at 300 g for 1 min and the pellet
resuspended in an equal volume of the supernatant. About 3 µL of the sample were
placed on a microscopy slide, mixed with 3 µL Vectashield, and covered with a
cover slip. Images were acquired with a Leica DM 5000B microscope and a Leica
DFC 345 FX camera using a 100x immersion oil objective (total magnification
=1250x). Filter block settings: mScarlet (Ex. 543/22 nm; Em. 593/40 nm), Hoechst
(Ex. 377/50 nm; Em. 447/60). All images were acquired using the Leica Application
Suite software (LAS 4.9.0) and processed using ImageJ (version 1.52n) using
identical settings.
Induction of sexual commitment and gametocytogenesis. Depending on the
inducible GDV1 overexpression system employed, induction of sexual commit-
ment was achieved by either stabilising GDV1-GFP-DD fusion protein expression
via addition of Shield-1 (+Shield-1) (3D7/iGP), or stabilisation of gdv1-gfp mRNA
via removal of GlcN (−GlcN) (NF54/iGP2 and NF54/iGP2_NUP313-mSc), or
combining both treatments simultaneously (−GlcN/+Shield-1) (NF54/iGP1). To
determine sexual conversion rates (SCRs), synchronous ring stage cultures at 1–3%
parasitaemia (0–16 hpi, generation 1) were washed in culture medium and split
into two identical cultures at 5% haematocrit. One was maintained under non-
inducing conditions (control population representing background SCRs) and the
other was induced for sexual conversion by triggering ectopic GDV1 expression
through the addition of 1350, 675, or 337.5 nM Shield-1 (3D7/iGP), addition of
1350 nM Shield-1/removal of GlcN (NF54/iGP1), or removal of GlcN (NF54/iGP2,
NF54/iGP2_NUP313-mSc). The inducing conditions were reversed 54 h later in
the ring stage progeny (6–22 hpi, generation 2; day 1 of gametocytogenesis). To
quantify SCRs, parasites were methanol-fixed at 36–44 hpi in generation 2 (day 2 of
gametocytogenesis) and α-Pfs16 IFAs combined with DAPI staining were per-
formed (see above). SCRs were determined as the proportion of early stage I
gametocytes (DAPI-positive/Pfs16-positive) among all infected RBCs (DAPI-
positive).
For gametocyte maturation assays, parasites were induced for sexual conversion
as describe above. Culture medium containing 50 mM GlcNAc was added to the
ring stage progeny (generation 2; day 1 of gametocytogenesis) and changed daily
for six days to eliminate asexual parasites53,68. From day seven onward,
gametocytes were cultured with normal culture medium. Gametocyte stages and
gametocytaemia were assessed by visual inspection of Giemsa-stained thin blood
smears prepared until day 12 of gametocytogenesis using a 100x immersion oil
objective (total magnification= 1000x).
Quantification of gametocyte sex ratios and exflagellation rates. To determine
the sex ratios of NF54/iGP1_D8 and NF54/iGP2_E9 gametocytes produced via
induction of ectopic GDV1 expression, ring stage parasites were treated with
−GlcN/+Shield-1 and −GlcN, respectively, and gametocytes cultured as explained
in the section above. To obtain sufficient quantities of control gametocytes
obtained without inducing ectopic GDV1 expression, sexual commitment rates of
NF54/iGP1_D8 (+GlcN/−Shield-1) and NF54/iGP2_E9 parasites (+GlcN) were
augmented using LysoPC-/choline-free minimal fatty acid medium (mFA) (RPMI
1640 medium, 25 mM HEPES, 24 mM sodium bicarbonate, 100 µM hypoxanthine,
0.39% fatty acid-free BSA (Sigma–Aldrich), 30 µM oleic acid, and 30 µM palmitic
acid)17. To quantify female/male gametocyte sex ratios, IFAs using antibodies
against the female-specific protein Pfg37769 were performed to identify female
(DAPI-positive/Pfg377-positive) and male stage V gametocytes (DAPI-positive/
Pfg377-negative) as explained above.
To quantify male gametocyte exflagellation, 10 μL of stage V gametocyte
cultures was added to 10 μL of 50 μM xanthurenic acid in incomplete RPMI 160
medium, placed into a Neubauer slide with rhodium-coated chamber bottom, and
incubated for 10–15 min at room temperature. The exflagellation events were
counted and the average per µl and 1% parasitaemia calculated.
Western blot analysis. Synchronous ring stage parasites were split at 0–8 hpi and
treated with +GlcN/−Shield-1, −GlcN/−Shield-1 or −GlcN/+Shield-1 (NF54/
iGP1_D8), and +GlcN or −GlcN (NF54/iGP2_E9). At 34–42 hpi, schizonts were
released from the iRBC by saponin lysis (0.15% in PBS) and whole-cell extracts
prepared by suspension of the parasite pellet in UREA/SDS lysis buffer [(8 M urea,
5% SDS, 50 mM Bis-Tris, 2 mM EDTA, pH 6.5, 1 mM TCEP, and 1x protease
inhibitor (Roche)]. To prepare protein extracts from gametocytes, parasite cultures
were induced for ectopic GDV1 expression by treatment with −GlcN/+Shield-1
(NF54/iGP1_D8) or −GlcN (NF54/iGP2_E9). The ring stage progeny were split
(generation 2; day 1 of gametocytogenesis) and cultured separately under +GlcN/
−Shield-1 or −GlcN/−Shield-1 conditions (NF54/iGP1_D8) and under +GlcN or
−GlcN conditions (NF54/iGP2_E9) with 50 mM GlcNAc added to the culture
medium for six days to eliminate asexual parasites53,68. Whole-cell extracts were
prepared from stage III gametocytes (day 6) as described above. Protein extracts
were separated on a NuPage 4–12% Bis-Tris gel (Novex) using NuPage MES SDS
Running Buffer (Novex). Proteins were detected with primary antibodies mouse
mAb α-GFP (1:1,000) (Roche Diagnostics #11814460001) and rabbit α-PfHP1
(1:14,000)12, and secondary antibodies α-mouse IgG (H&L)-HRP (1:10,000)
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(GE Healthcare #NXA931) and α-rabbit IgG (H&L)-HRP (1:10,000) (GE Health-
care #NA934). Chemiluminescence signals were detected using the KPL LumiGLO
Reserve Chemiluminescent Substrate Kit (SeraCare #5430-0049).
Standard membrane feeding assays (SMFAs). On day 10, 13, and 14 of
gametocytogenesis, aliquots of stage-V gametocyte cultures were tested in the
Standard Membrane Feeding Assay (SMFA)65 according to an established
workflow70. Briefly, after a final change of culture medium on the day of mosquito
feeding, a small volume of the gametocyte culture was used to prepare the blood
meal and to make blood smears. About 300 µL of the gametocyte culture
(approximately 2.5% hamatocrit and 3–10% gametocytemia) was mixed with
prewarmed 180 µL of packed RBCs and the cells were pelleted for 20 sec. The
supernatant was carefully removed and the RBC pellet resuspended in 150 µL of
prewarmed human serum. Small membrane feeders were used to feed female
Anopheles stephensi mosquitoes separately with each of the prepared gametocyte
populations (approximately 0.15–0.5% gametocytemia and 50% hematocrit). For
sporozoite production experiments, midi membrane feeders were used with three
times the above volumes with the ratios consistent to feed 100 mosquitoes65. On
day 8 after feeding, midguts of 20 mosquitoes per feed were dissected and stained
for oocysts using 3% mercurochrome. The numbers of oocysts per midgut were
counted by microscopy (1000x magnification). For sporozoite collection on day 17,
at least 25 mosquitoes were dissected with salivary glands collected and crushed in
complete Williams B media at room temperature. Sporozoites were counted using a
Neubauer slide with rhodium-coated chamber bottom and used directly for
hepatocyte infection assays.
Hepatocyte infection assay. Fresh human hepatocytes were isolated from patients
undergoing a partial hepatectomy and seeded (6 × 104 hepatocytes/well) onto
collagen-coated 96-well black/clear flat-bottom TC-treated imaging microplates
(Corning, #353219) in complete Williams B medium and incubated at 37 °C in 5%
CO299. On day 3 after seeding, sporozoites were added (6 × 104 sporozoites/well),
spun down at 500 g for 5 min, and allowed to invade hepatocytes for three hours.
The wells were washed in complete Williams B medium and incubated at 37 °C in
5% CO2, with the medium changed every day99. Plates were fixed with ice-cold
methanol on days 3 and 5 and used for IFA analysis as described above.
Ethical statement. Primary human liver cells were freshly isolated from remnant
surgical material. The samples were anonymized, and general approval for use of
remnant surgical material was granted in accordance with the Dutch ethical leg-
islation as described in the Medical Research (Human Subjects) Act and confirmed
by the Committee on Research involving Human Subjects, in the region of
Arnhem–Nijmegen, the Netherlands.
Statistics and reproducibility. All data from assays quantifying sexual commit-
ment rates, gametocyte staging, gametocyte sex ratios, exflagellation rates, mos-
quito infection rates, and oocyst and sporozoite production are represented in
graphs showing individual data points and the mean with error bars defining the
standard deviation, or the median and interquartile ranges as indicated in the figure
legends and the Source data file. To test for statistical significance of the difference
in gametocyte sex ratios, a paired two-tailed Student’s t test was used as indicated
in the figure legend. The exact number of biological replicates performed per
experiment and the number of cells analysed per sample are indicated in the figure
legends and the Source data file. Data were analysed using Excel 2016 and plotted
using GraphPad Prism (version 8.2.1).
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All data generated or analysed during this study are included in this published article and
its associated Supplementary Information and Source data files. The associated Source
data file contains the raw data underlying the graphs presented in Figs. 1d, 2b, 2e, 2g, 3a,
3b and Supplementary Figs. 2b, 5a, 6b–d, 7a-b. Correspondence and requests for
materials should be addressed to T.S.V. Source data are provided with this paper.
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